Metabolomic profiling in small vessel disease identifies multiple associations with disease severity

Cerebral small vessel disease is a major cause of vascular cognitive impairment and dementia. There are few treatments, largely reflecting limited understanding of the underlying pathophysiology. Metabolomics can be used to identify novel risk factors to better understand pathogenesis and to predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Harshfield, Eric L, Sands, Caroline J, Tuladhar, Anil M, de Leeuw, Frank Erik, Lewis, Matthew R, Markus, Hugh S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337813/
https://www.ncbi.nlm.nih.gov/pubmed/35254405
http://dx.doi.org/10.1093/brain/awac041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337813/
https://www.ncbi.nlm.nih.gov/pubmed/35254405
http://dx.doi.org/10.1093/brain/awac041

Ejemplares similares